Production (Stage)
Elanco Animal Health Incorporated
ELAN
$13.81
-$0.36-2.54%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 67.00M | -8.00M | 364.00M | -50.00M | 32.00M |
| Total Depreciation and Amortization | 161.00M | 124.00M | 170.00M | 162.00M | 166.00M |
| Total Amortization of Deferred Charges | -- | 40.00M | -- | -- | -- |
| Total Other Non-Cash Items | 5.00M | -35.00M | -620.00M | 66.00M | -19.00M |
| Change in Net Operating Assets | -237.00M | 56.00M | 248.00M | 22.00M | -177.00M |
| Cash from Operations | -4.00M | 177.00M | 162.00M | 200.00M | 2.00M |
| Capital Expenditure | -65.00M | -47.00M | -42.00M | -34.00M | -24.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -36.00M | 0.00 | 0.00 | -- |
| Divestitures | 9.00M | 0.00 | 1.29B | 0.00 | 66.00M |
| Other Investing Activities | -2.00M | -7.00M | -8.00M | 1.00M | -5.00M |
| Cash from Investing | -58.00M | -90.00M | 1.24B | -33.00M | 37.00M |
| Total Debt Issued | 250.00M | 0.00 | 350.00M | 120.00M | 100.00M |
| Total Debt Repaid | -178.00M | -38.00M | -1.68B | -212.00M | -113.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -20.00M | 6.00M | -8.00M | -1.00M | -14.00M |
| Cash from Financing | 52.00M | -32.00M | -1.34B | -93.00M | -27.00M |
| Foreign Exchange rate Adjustments | 29.00M | -77.00M | 8.00M | -3.00M | -19.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.00M | -22.00M | 74.00M | 71.00M | -7.00M |